Estimating incidence of HIV infection in Uganda [2]

JAMA

Volumn 301, Issue 2, 2009, Pages 159-160

  Todd, Jim ^a   Lutalo, Tom ^b   Kaleebu, Pontiano ^c  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPED COUNTRY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LABORATORY TEST; LETTER; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; UGANDA; NOTE;

HIV INFECTIONS; HUMANS; INCIDENCE; UGANDA;

EID: 58249090332     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.954     Document Type: Letter

References (4)

1. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in Uganda. JAMA. 2008;300(5):540-549.
2. Shafer LA, Biraaro S, Nakiyingi-Miiro J, et al. HIV prevalence and incidence are no longer falling in southwest Uganda: evidence from a rural population cohort 1989-2005. AIDS. 2008;22(13):1641-1649.
3. Karita E, Price M, Hunter E, et al; IAVI Collaborative Seroprevalence and Incidence Study Team. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS. 2007;21(4):403-408.
4. Interim recommendations for the use of the BED capture enzyme immunoassay for incidence estimation and surveillance (November 21, 2006). US Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchstp/od/GAP/docs/ surveillance/ Interim%20Recommendations%20for%20the%20use%20of%20the%20BED%20capture%20 enzyme%20immunoassay%20for%20incidence%20estimation%20and%20surveillance%20 Approved%20November%2021%202006%20(2).pdf. Accessed August 8, 2008.